DALLANOCE, CLELIA MARIANGIOLA LUISA
DALLANOCE, CLELIA MARIANGIOLA LUISA
Dipartimento di Scienze Farmaceutiche
New Alpha9 nAChR Ligands Based on a 5-(Quinuclidin-3-ylmethyl)-1,2,4-oxadiazole Scaffold
2024 C. Dallanoce, K. Richter, C. Stokes, C. Papotto, H. Andleeb, G.A. Thakur, A. Kerr, V. Grau, R.L. Papke
M2 Muscarinic Receptor Stimulation Induces Autophagy in Human Glioblastoma Cancer Stem Cells via mTOR Complex-1 Inhibition
2024 C. Guerriero, M. Manfredelli, C. Matera, A. Iuzzolino, L. Conti, C. Dallanoce, M. De Amici, D. Trisciuoglio, A.M. Tata
M2 Muscarinic Receptor Stimulation Induces Autophagy in Human Glioblastoma Cancer Stem Cells via mTOR Complex-1 Inhibition
2023 C. Guerriero, M. Manfredelli, C. Matera, A. Iuzzolino, L. Conti, C. Dallanoce, M. DE AMICI, D. Trisciuoglio, A. Maria Tata
α7 Nicotinic Acetylcholine Receptors May Improve Schwann Cell Regenerating Potential via Metabotropic Signaling Pathways
2023 E. Botticelli, C. Guerriero, S. Fucile, M. Egle De Stefano, C. Matera, C.M.L. Dallanoce, M. DE AMICI, A. Maria Tata
Targeting the D3R-nAChR heteromeric complex for nicotine cessation
2023 V. Lallai, C. Matera, K. Bodinayake, C.M.L. Dallanoce, C. Fowler
Novel Xanomeline-Containing Bitopic Ligands of Muscarinic Acetylcholine Receptors: Design, Synthesis and FRET Investigation
2023 C. Matera, M. Kauk, D. Cirillo, M. Maspero, C. Papotto, D. Volpato, U. Holzgrabe, M. DE AMICI, C. Hoffmann, C.M.L. Dallanoce
Advances in small molecule selective ligands for heteromeric nicotinic acetylcholine receptors
2023 C. Matera, C. Papotto, C. Dallanoce, M. De Amici
Identification of novel potential B4GALT6 inhibitors through a large scale virtual screening
2022 C. Papotto, E. Sabato, D. Lecca, C. Matera, M. DE AMICI, A. Pedretti, C.M.L. Dallanoce, G. Vistoli
Alteration of the mitochondrial activity and lipidic metabolism caused by the selective stimulation of M2 muscarinic receptors in human glioblastoma cells
2022 C. Guerriero, M. Salazar Intriago, A. Giudetti, M. Manfredelli, M. Petrone, S. Tacconi, T. Rinaldi, C. Matera, S. Visentin, A. Iuzzolino, C.M.L. Dallanoce, L. Dini, A. Maria Tata
Optical control of dopamine receptors in vitro and in vivo with photoswitchable ligands
2022 C. Matera, S. Roda, S. Redondi, P. Calvé, V. Casadó-Anguera, R. Sortino, A.M.J. Gomila, E. Moreno, T. Gener, C. Delgado, P. Nebot, D. Discacciati, J. Hernando, V. Straniero, G. Vistoli, E. Valoti, M. De Amici, C. Dallanoce, V. Casadó, M.V. Puig, P. Gorostiza
Iperoxo/dequalinium and W84/dequalinium hybrid ligands: synthesis, pharmacological and computational investigation at M2 mAChRs
2022 C. Papotto, C. Matera, N. Brivio, M. Maspero, M. De Amici, S. Morando, R. Matucci, G. Vistoli, C. Dallanoce
The Exception That Proves the Rule: How Sodium Chelation Can Alter the Charge-Cell Binding Correlation of Fluorescein-Based Multimodal Imaging Agents
2022 M. Maspero, C. Dallanoce, B. Wangler, C. Wangler, R. Hubner
Recent Advances in the Modulation of Cholinergic Signaling
2022 C. Dallanoce
Photoswitchable ligands for light-mediated control of α7 nicotinic acetylcholine receptors: design, synthesis and photochromic characterization
2021 C. Papotto, R. Sortino, H. Lee, B. Preda, C. Matera, M. De Amici, P. Gorostiza, C. Dallanoce
Photoswitchable ligands for the optical control of α7 nicotinic acetylcholine receptors: synthesis and photochromic characterization
2021 C. Papotto, R. Sortino, H. Lee, B. Preda, C. Matera, M. De Amici, P. Gorostiza, C. Dallanoce
Pesin conjugates for multimodal imaging : Can multimerization compensate charge influences on cell binding properties? a case study†
2021 R. Hubner, A. Paretzki, V. von Kiedrowski, M. Maspero, X. Cheng, G. Davarci, D. Braun, H. Damerow, B. Judmann, V. Filippou, C. Dallanoce, R. Schirrmacher, B. Wangler, C. Wangler
The Combined Treatment with Chemotherapeutic Agents and the Dualsteric Muscarinic Agonist Iper-8-Naphthalimide Affects Drug Resistance in Glioblastoma Stem Cells
2021 C. Guerriero, C. Matera, D. Del Bufalo, M. DE AMICI, L. Conti, C.M.L. Dallanoce, A. Maria Tata
Stable desensitization of α7 nicotinic acetylcholine receptors by NS6740 requires interaction with S36 in the orthosteric agonist binding site
2021 M.C. Pismataro, N.A. Horenstein, C. Stokes, C. Dallanoce, G.A. Thakur, R.L. Papke
Modulation of the D3R-nAChR Heteromeric Complex Attenuates Nicotine Self-Administration
2021 V. Lallai, C. Matera, K. Bodinayake, C. Papotto, C.M.L. Dallanoce, C. Fowler
Combined treatments with the dualsteric agonist N-8-Iper plus chemotherapy drugs affect drug resistance in glioblastoma cancer stem cells
2021 C. Guerriero, C. Matera, D. Del Bufalo, M. De Amici, L. Conti, C. Dallanoce, A.M. Tata